By William Gullotti
Buffalo, N.Y., June 14 – Citigroup Global Markets Holdings Inc. priced $665,000 of 0% barrier securities due May 26, 2026 linked to the worst performing of the ARK Genomic Revolution ETF and the ARK Innovation ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Citigroup Inc.
If the final level of the worse performing ETF is greater than or equal to its initial level, the payout at maturity will be par plus 115% of the return of that ETF.
If the final level of the worse performing ETF is less than its initial level but greater than or equal to its 75% barrier level, the payout will be par.
If the final level of the worse performing ETF is less than the 75% barrier level, investors will be fully exposed to the decline of the worse performing ETF.
Citigroup Global Markets Inc. is the underwriter.
| Issuer: | Citigroup Global Markets Holdings Inc.
|
| Guarantor: | Citigroup Inc.
|
| Issue: | Barrier securities
|
| Underlying ETFs: | ARK Genomic Revolution ETF and ARK Innovation ETF
|
| Amount: | $665,000
|
| Maturity: | May 26, 2026
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If the final level of the worse performing ETF is greater than or equal to its initial level, par plus 115% of the return of that ETF; if the final level of the worse performing ETF is less than its initial level but greater than or equal to its barrier level, par; otherwise, full exposure to the decline of the worse performing ETF
|
| Initial levels: | $78.77 for Genomic, $106.59 for Innovation
|
| Barrier levels: | $59.078 for Genomic, $79.943 for Innovation; 75% of initial levels
|
| Pricing date: | May 20
|
| Settlement date: | May 25
|
| Underwriter: | Citigroup Global Markets Inc.
|
| Fees: | 0.75%
|
| Cusip: | 17329FMC5
|
|
|
|
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
